Literature DB >> 24095729

Structural insights into RIP3-mediated necroptotic signaling.

Tian Xie1, Wei Peng, Chuangye Yan, Jianping Wu, Xinqi Gong, Yigong Shi.   

Abstract

RIP3 is an essential upstream kinase in necroptosis. The pseudokinase MLKL functions as a substrate of RIP3 to mediate downstream signaling. The molecular mechanism by which RIP3 recognizes and phosphorylates MLKL remains unknown. Here, we report the crystal structures of the mouse RIP3 kinase domain, the MLKL kinase-like domain, and a binary complex between the two. Both RIP3 and MLKL adopt the canonical kinase fold. Free RIP3 exists in an active conformation, whereas MLKL-bound RIP3 is stabilized by AMP-PNP to adopt an inactive conformation. The formation of the RIP3-MLKL complex, involving their respective N- and C-lobes, is accompanied by pronounced conformational changes of the αC helix and activation loop in RIP3 and the corresponding structural elements in MLKL. RIP3-mediated MLKL phosphorylation, though important for downstream signaling, is dispensable for stable complex formation between RIP3 and MLKL. Our study serves as a framework for mechanistic understanding of RIP3-mediated necroptotic signaling.
Copyright © 2013 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24095729     DOI: 10.1016/j.celrep.2013.08.044

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  78 in total

1.  Herpes simplex virus 1 ICP6 impedes TNF receptor 1-induced necrosome assembly during compartmentalization to detergent-resistant membrane vesicles.

Authors:  Mohammad Ali; Linda Roback; Edward S Mocarski
Journal:  J Biol Chem       Date:  2018-11-30       Impact factor: 5.157

2.  Shikonin induces apoptosis and necroptosis in pancreatic cancer via regulating the expression of RIP1/RIP3 and synergizes the activity of gemcitabine.

Authors:  Congying Chen; Wenqin Xiao; Li Huang; Ge Yu; Jianbo Ni; Lijuan Yang; Rong Wan; Guoyong Hu
Journal:  Am J Transl Res       Date:  2017-12-15       Impact factor: 4.060

Review 3.  Regulated necrosis: the expanding network of non-apoptotic cell death pathways.

Authors:  Tom Vanden Berghe; Andreas Linkermann; Sandrine Jouan-Lanhouet; Henning Walczak; Peter Vandenabeele
Journal:  Nat Rev Mol Cell Biol       Date:  2014-02       Impact factor: 94.444

Review 4.  Regulation of tumour necrosis factor signalling: live or let die.

Authors:  Dirk Brenner; Heiko Blaser; Tak W Mak
Journal:  Nat Rev Immunol       Date:  2015-06       Impact factor: 53.106

Review 5.  True grit: programmed necrosis in antiviral host defense, inflammation, and immunogenicity.

Authors:  Edward S Mocarski; William J Kaiser; Devon Livingston-Rosanoff; Jason W Upton; Lisa P Daley-Bauer
Journal:  J Immunol       Date:  2014-03-01       Impact factor: 5.422

6.  The MLKL Channel in Necroptosis Is an Octamer Formed by Tetramers in a Dyadic Process.

Authors:  Deli Huang; Xinru Zheng; Zi-An Wang; Xin Chen; Wan-Ting He; Yingying Zhang; Jin-Gen Xu; Hang Zhao; Wenke Shi; Xin Wang; Yongqun Zhu; Jiahuai Han
Journal:  Mol Cell Biol       Date:  2017-02-15       Impact factor: 4.272

Review 7.  The Inflammatory Signal Adaptor RIPK3: Functions Beyond Necroptosis.

Authors:  K Moriwaki; F K-M Chan
Journal:  Int Rev Cell Mol Biol       Date:  2016-09-22       Impact factor: 6.813

Review 8.  Ars Moriendi; the art of dying well - new insights into the molecular pathways of necroptotic cell death.

Authors:  James M Murphy; John Silke
Journal:  EMBO Rep       Date:  2014-01-27       Impact factor: 8.807

9.  Kinase domain dimerization drives RIPK3-dependent necroptosis.

Authors:  Saravanan Raju; Daniel M Whalen; Meron Mengistu; Carter Swanson; John G Quinn; Susan S Taylor; Joshua D Webster; Kim Newton; Andrey S Shaw
Journal:  Sci Signal       Date:  2018-08-21       Impact factor: 8.192

10.  Structural Basis for Noncanonical Substrate Recognition of Cofilin/ADF Proteins by LIM Kinases.

Authors:  Stephanie Hamill; Hua Jane Lou; Benjamin E Turk; Titus J Boggon
Journal:  Mol Cell       Date:  2016-05-05       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.